In a rare move, maker of failed ALS drug removes it from the market
Daniel Gilbert
Amylyx Pharmaceuticals said it would voluntarily remove its FDA-approved drug for amyotrophic lateral sclerosis from the market after a trial showed it doesn't work.
Work Advice: Is that chill in the air retaliation from my employer?
Karla Miller
A worker is noticing a change in co-workers' behavior and has been passed up for a project. Could it be retaliation for a complaint filed months ago?
Can kosher food be hip? Manischewitz is betting its rebrand on it.
Jaclyn Peiser
The 136-year-old brand known for its Passover offerings hopes its revamp will appeal to the culturally curious.